Abstracts Archive - Page 268 of 1683 - ATC Abstracts

2021 American Transplant Congress
Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience
M. Haberal¹, E. Karakaya¹, A. Akdur¹, E. Ayvazoglu Soy¹, F. Ozcay², E. Baskin³, S. Boyacioglu⁴, A. Torgay⁵, S. Yildirim¹, G. Moray¹, F. Yarbug Karakayali¹
¹Division of Transplantation, Department of General Surgery, Baskent University, Ankara, Turkey, ²Department of Pediatric Gastroenterology, Baskent University, Ankara, Turkey, ³Department of Pediatric Nephrology, Baskent University, Ankara, Turkey, ⁴Department of Gastroenterology, Baskent University, Ankara, Turkey, ⁵Department of Anaesthesiology, Baskent University, Ankara, Turkey
*Purpose: Introduction: Beginning of this year, when the Covid-19 pandemic has first started, it had the immediate effect of severely reducing living and deceased organ…
2021 American Transplant Congress
Quantification of Multiple Isotypes of Anti-SARS-CoV-2 Antibodies in Kidney Transplant Recipients
J. S. Maltzman¹, L. Wang¹, P. Ahearn¹, T. Yalamarti¹, M. Menon², Y. Azzi³, M. Melcher¹, M. Fernandez-Vina¹, R. Bray⁴, H. Gebel⁴, E. Woodle⁵, E. Akalin³, A. Girnita¹, P. Cravedi²
¹Stanford University, Palo Alto, CA, ²Icahn School of Medicine, NYC, NY, ³Einstein School of Medicine, NYC, NY, ⁴Emory University, Atlanta, GA, ⁵University of Cincinnati, Cincinnati, OH
*Purpose: Solid organ transplant recipients are at increased risk of severe outcomes with infection by SARS-CoV-2, the etiologic agent of COVID-19. Antibodies directed against the…
2021 American Transplant Congress
Panic in the Pandemic: A Medical Decision Analysis Examining When Kidney Transplant Programs Should Close
A. J. Vinson¹, B. Kiberd², K. Tennankore¹
¹Nova Scotia Health Authority Division of Nephrology, Departm, Halifax, NS, Canada, ²Dalhousie University, Halifax, NS, Canada
*Purpose: Pandemics greatly interfere with overall health care delivery as resources are diverted to combat the crisis. Kidney transplantation programs were closed temporarily during the…
2021 American Transplant Congress
Covid-19 Infections Post-liver and Kidney Transplantation in a Southern Ca Program
M. E. de Vera¹, J. Woloszyn², S. Regmi², R. Rattanavich², M. Rakoski², M. Lin², P. Mehta², A. Kore², J. Weissman², C. Martens², T. Phan², B. Jerez-Aguilar², M. Robinson², E. Wells², R. Villicana², M. Nguyen²
¹Loma Linda University Health, San Bernardino, CA, ²Transplant Institute, Loma Linda University Health, San Bernardino, CA
*Purpose: Southern CA is at the epicenter of the Covid-19 pandemic. We reviewed outcomes of our center's liver, kidney, and pancreas transplant patients stricken with…
2021 American Transplant Congress
White, Older Men Are Less Affected by the Changes of the Covid-19 Pandemic
R. J. Berkowitz, A. Daud, S. Brietigam, T. S. Taylor, J. Carter, M. A. Callegari, B. Borja-Cacho, J. C. Caicedo, D. Simpson, D. P. Ladner
Surgery, Northwestern Medicine, Chicago, IL
*Purpose: This study explores quality of life and lifestyle changes due to the COVID-19 pandemic among pre- and post- liver (LT) and kidney (KT) transplant…
2021 American Transplant Congress
Clinically Evident Portal Hypertension (CEPH) is Associated with Low IGF-1 in Children with Chronic Liver Disease
B. Whitehead¹, S. Mohammad¹, S. Kelly¹, J. Josefson², L. Mithal³, E. M. Alonso¹
¹Division of Gastroenterology, Hepatology and Nutrition, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, ²Division of Endocrinology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, ³Division of Infectious Disease, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
*Purpose: Children with chronic liver disease exhibit growth hormone resistance which is an additional risk factor for sarcopenia and growth failure in this vulnerable population.…
2021 American Transplant Congress
A Case-Match Cohort Comparison of the Safety and Efficacy of Basiliximab for Immunosuppression Holiday in Lung Transplant Patients
M. M. Eiting¹, J. E. Clark¹, T. L. Astor², J. Palafox², C. Rogers Marks¹, G. Waldman¹
¹Pharmacy, Massachusetts General Hospital, Boston, MA, ²Massachusetts General Hospital, Boston, MA
*Purpose: Post-transplant complications related to calcineurin inhibitors (CNI) maintenance immunosuppression (MI) may require interim alternative therapies. The goal of this study is to evaluate the…
2021 American Transplant Congress
Trends in Living Donor Transplantation in USA
N. Kemmer, C. Albers, S. Agrawal, R. Syed, M. Malespin, J. Buggs
Tampa General Hospital, Tampa, FL
*Purpose: Globally, living donation has improved access to organ transplantation and saved the lives of individuals with end-stage kidney disease and end-stage liver disease. In…
2021 American Transplant Congress
Use of Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients: A Scoping Review
A. G. Anderson, M. Eubank, K. Murray
University of Missouri, Columbia, MO
*Purpose: Immune checkpoint inhibitors (ICI) are an emerging treatment for numerous advanced diseases, but their safety and efficacy in immunosuppressed transplant patients is not known.…
2021 American Transplant Congress
Seasonality of Mortality for Solid Organ Waitlist Candidates
J. Miller, D. Musgrove
SRTR, Minneapolis, MN
*Purpose: Analysis of the impact of policies or natural occurrences on transplant system outcomes requires comparison of a treatment (post-policy) period to a control (pre-policy)…